SRXHConsumer Defensive · Packaged Foods

SRXH Stock Forecast: SRX Global, Inc. Price Predictions for 2026-2027

Last close, 21 Aug 2026

$1.86

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 2 of 100 as at 22 Aug 2026 — in the weakest quartile.

Market cap

$26.6M

Ticker Nerd rank

2 / 100

Median analyst target

—

Analysts covering

—

Ticker Nerd rank

SRXH stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores SRX Global, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 22 Aug 2026

2 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size

Revisions

Issuance

Momentum

Volatility

Accruals

Quality

Value

Growth

Size (85): Smaller than most of the companies we track.

Growth (1): Sales and profits are flat, shrinking, or growing more slowly than they were.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

SRXH stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on SRXH, reported as data — targets and ratings, the market's view beside the model's.

We don’t hold enough price history for this company yet.

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. SRXH appears on the weeks it earns a place.

Estimates

SRXH analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

SRX Global, Inc. (SRXH) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation

Trailing P/E: −0.0×
Price / sales: 4.1×
Price / book: 0.6×
EV / EBITDA: −2.6×

Growth & margins

Revenue growth (YoY): 22.5%
Earnings growth (YoY): −52.0%
Gross margin: 37.1%
Operating margin: −122.6%
Net margin: 23.4%

Returns & dividend

Return on equity: −11058.0%
Return on assets: −535.7%
Dividend yield: —

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

SRXH vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelPackaged Foods

Company	Market cap	TKN rank
SRXHSRX Global, Inc.	$26.6M	2
BRLSBorealis Foods, Inc.	$39.7M	46
LSFLaird Superfood, Inc.	$41.5M	20
DDCDDC Enterprise Ltd.	$29.7M	2
BHSTBioHarvest Sciences, Inc.	$45.4M	41
CLNNClene, Inc.	$55.2M	28
BRIDBridgford Foods Corp.	$57.0M	35

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own SRX Global, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest SRXH news & analysis

SRX Global Inc. Announces Fiscal Third Quarter 2026 Financial Results

GlobeNewsWire · 13 Aug 2026positive

SRX Global Inc. announced its fiscal third quarter 2026 financial results, reporting a Net Asset Value of $62.9 million ($3.22 per share), exceeding its preliminary estimate, with no debt outstanding and an improved Adjusted EBITDA loss.

Why it matters — The company reported stronger-than-expected NAV per share, improved operational performance with 98% fill rates at Halo, and a 35% year-over-year improvement in Adjusted EBITDA loss, indicating financial progress.

SRX Global to Host Fiscal Third Quarter 2026 Conference Call on August 13 at 4:30 p.m. ET

GlobeNewsWire · 6 Aug 2026neutral

SRX Global, Inc. (NYSE American: SRXH) announced it will host a conference call and report its financial results for the fiscal third quarter ended June 30, 2026, on Thursday, August 13, 2026, at 4:30 p.m. ET.

Why it matters — SRXH watchers will be able to hear the company's fiscal third-quarter results and commentary directly from management on the scheduled call.

SRX Global Acquires Stake in Vistagen Therapeutics (NASDAQ: VTGN)

GlobeNewsWire · 4 Aug 2026positive

SRX Global, Inc. announced it has acquired a stake in Vistagen Therapeutics, a late clinical-stage biopharmaceutical company developing intranasal neuroscience product candidates called pherines. The investment adds Vistagen to SRX's holdings of operating companies and strategic assets.

Why it matters — SRXH watchers would care because the acquisition expands SRX's investment portfolio with a stake in a late-stage biopharmaceutical company focused on neuroscience drug development.

SRX Global Portfolio Company Smartkem, Inc. (NASDAQ: SMTK) Announces Merger

GlobeNewsWire · 3 Aug 2026positive

SRX Global, Inc. (NYSE American: SRXH) announced that its portfolio company Smartkem, Inc. (NASDAQ: SMTK), a leader in advanced materials, will merge with Ferrox Critical Minerals, a move it said strengthens critical minerals sourcing.

Why it matters — The merger involves an SRX portfolio company, so the development could affect the value of SRX's investment portfolio.

SRX Global Acquires Shares in Jersey Mike's $1 Billion Initial Public Offering

GlobeNewsWire · 30 July 2026positive

SRX Global Inc. announced it acquired shares in the initial public offering of Jersey Mike's, a fast-casual restaurant franchisor, which priced at $23.00 per share at a $1 billion valuation and began trading on the NYSE under the ticker JMKE.

Why it matters — SRXH shareholders may view this as an investment by the company into a high-profile IPO, potentially contributing to SRX Global's portfolio of strategic assets.

FAQ

Frequently asked questions about SRXH stock

How does Ticker Nerd's model rank SRXH?

As at 22 Aug 2026, SRX Global, Inc. ranks 2 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (85 of 100).

What is the SRXH stock forecast for 2030?

No analyst covering SRX Global, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for SRXH are extrapolating price history, which says nothing about the business.

What does SRX Global, Inc. do?

SRx Health Solutions Inc. is an integrated healthcare services provider specializing in the delivery of comprehensive medical and wellness solutions across Canada.

What is the latest news on SRXH?

The most recent item we track (GlobeNewsWire, 13 Aug 2026): "SRX Global Inc. Announces Fiscal Third Quarter 2026 Financial Results". SRX Global Inc. announced its fiscal third quarter 2026 financial results, reporting a Net Asset Value of $62.9 million ($3.22 per share), exceeding its preliminary estimate, with no debt outstanding and an improved Adjusted EBITDA loss.

Company

About SRX Global, Inc.

SRx Health Solutions Inc. is an integrated healthcare services provider specializing in the delivery of comprehensive medical and wellness solutions across Canada. Established in 2013 and headquartered in Toronto, the company offers a diverse portfolio of healthcare services, including pharmacy operations, compounding services, nursing care, clinic and vaccination services, diabetes management, travel health support, tuberculosis testing, and HIV prevention programs. SRx Health Solutions is recognized for operating both specialty and retail-owned pharmacies and has also delivered services such as COVID-19 testing. Its expansive network spans all ten Canadian provinces, making it one of the country's most accessible providers of customized specialty healthcare services. The company leverages industry expertise, advanced technology, and a patient-centric approach to enhance care quality and drive critical patient wellness initiatives. Following a recent merger, SRx Health Solutions has broadened its impact to serve both people and pets, aiming to set new standards in specialty healthcare and wellness for individuals, families, and companion animals alike.

CEO Dr. Eric M. Jackson Ph.D. · 7 employees · United States · https://www.srxglobalinc.com